OTCMKTS:QTXB QuantRx Biomedical (QTXB) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free QTXB Stock Alerts $0.0040 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$0.0040▼$0.004050-Day Range N/A52-Week Range$0.0002▼$0.01VolumeN/AAverage VolumeN/AMarket Capitalization$314,800.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest Get QuantRx Biomedical alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About QuantRx BiomedicalQuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.Read More QTXB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QTXB Stock News HeadlinesApril 17, 2024 | morningstar.comQuantrx Biomedical Corp QTXBFebruary 12, 2023 | finance.yahoo.comGlobal Biomedical Tester Market Research Report 2022-2032April 26, 2024 | Stansberry Research (Ad)World’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.January 14, 2023 | seekingalpha.comLifecore Biomedical receives non-compliance notice from NasdaqSeptember 14, 2022 | reuters.comQTXB.PK - | Stock Price & Latest News | ReutersJuly 19, 2022 | benzinga.comQuantrx Biomedical (OTC:QTXB), Earnings Estimates, EPS, and RevenueJuly 19, 2022 | benzinga.comQuantrx Biomedical (OTC:QTXB), Analyst Ratings, Price Targets, PredictionsSee More Headlines Receive QTXB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolOTCMKTS:QTXB CUSIPN/A CIK820608 Webwww.quantrx.com Phone(212) 980-2235Fax1-267-880-1596EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares78,700,000Free Float61,462,000Market Cap$314,800.00 OptionableNot Optionable Beta-2.13 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Shalom Z. Hirschman M.D. (Age 88)Chairman of the Board, CEO & Principal Accounting Officer Key CompetitorsMotus GINASDAQ:MOTSPresbiaOTCMKTS:LENSFVerisante TechnologyOTCMKTS:VRSEFTodos MedicalOTCMKTS:TOMDFH-CYTEOTCMKTS:HCYTDView All Competitors QTXB Stock Analysis - Frequently Asked Questions How have QTXB shares performed in 2024? QuantRx Biomedical's stock was trading at $0.0079 at the beginning of 2024. Since then, QTXB shares have decreased by 49.4% and is now trading at $0.0040. View the best growth stocks for 2024 here. What other stocks do shareholders of QuantRx Biomedical own? Based on aggregate information from My MarketBeat watchlists, some companies that other QuantRx Biomedical investors own include Consorcio ARA, S. A. B. de C. V. (CNRFF), Auxly Cannabis Group (CBWTF), Christopher & Banks (CBK), Babcock & Wilcox Enterprises (BW), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH), Amerigo Resources (ARREF), Blue Apron (APRN), Africa Oil (AOIFF) and Galiano Gold (AKG). How do I buy shares of QuantRx Biomedical? Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:QTXB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QuantRx Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
